Cargando…

Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma

Long non-coding RNAs (lncRNAs) were shown to be the crucial regulators of the many diseases. In this study, the expressions of lncRNAs were investigated in resected 158 hepatocellular carcinomas (HCCs) to evaluate the effects of their expression levels on prognosis. The expression levels of HULC and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonohara, Fuminori, Inokawa, Yoshikuni, Hayashi, Masamichi, Yamada, Suguru, Sugimoto, Hiroyuki, Fujii, Tsutomu, Kodera, Yasuhiro, Nomoto, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700934/ https://www.ncbi.nlm.nih.gov/pubmed/29170515 http://dx.doi.org/10.1038/s41598-017-16260-1

Ejemplares similares

Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma: A Retrospective Study of 214 Consecutive Cases
por: Sonohara, Fuminori, et al.
Publicado: (2015)

Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis
por: Inokawa, Yoshikuni, et al.
Publicado: (2013)

Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma
por: Nakagawa, Nobuhiko, et al.
Publicado: (2021)

Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue
por: Sunagawa, Yuki, et al.
Publicado: (2021)

Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis
por: Inokawa, Yoshikuni, et al.
Publicado: (2013)

Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
por: Umeda, Shinichi, et al.
Publicado: (2017)

Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy
por: Sunagawa, Yuki, et al.
Publicado: (2021)

Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
por: Hayashi, Masamichi, et al.
Publicado: (2014)

Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
por: Kimura, Nana, et al.
Publicado: (2020)

Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2014)

Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy
por: HASHIMOTO, RYOJI, et al.
Publicado: (2015)

Multicenter randomized phase II trial of prophylactic right‐half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer
por: Yamada, Suguru, et al.
Publicado: (2020)

Clip-guided local duodenectomy for safe and minimal local resection of nonampullary duodenal neoplasms
por: Miwa, Takeshi, et al.
Publicado: (2022)

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy
por: Shimizu, Dai, et al.
Publicado: (2017)

Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer
por: Tanaka, Nobutake, et al.
Publicado: (2018)

Short-term outcomes after conventional transthoracic esophagectomy
por: Niwa, Yukiko, et al.
Publicado: (2016)

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy
por: Miwa, Takashi, et al.
Publicado: (2019)

Genomic-Wide Analysis with Microarrays in Human Oncology
por: Inaoka, Kenichi, et al.
Publicado: (2015)

Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2018)

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma
por: Kanda, Mitsuro, et al.
Publicado: (2017)

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy
por: Niwa, Yukiko, et al.
Publicado: (2019)

Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment
por: Fujii, Tsutomu, et al.
Publicado: (2015)

Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer
por: Sakata, Kazuki, et al.
Publicado: (2022)

HULC: an oncogenic long non‐coding RNA in human cancer
por: Yu, Xin, et al.
Publicado: (2016)

Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers
por: Shinozuka, Takahiro, et al.
Publicado: (2023)

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study
por: Takano, Nao, et al.
Publicado: (2019)

Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms
por: Zhang, Tao, et al.
Publicado: (2018)

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2014)

Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial
por: Yamada, Suguru, et al.
Publicado: (2018)

Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2016)

Modified two‐dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer
por: Nakayama, Goro, et al.
Publicado: (2016)

HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2
por: Wu, Mengying, et al.
Publicado: (2016)

A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients
por: Suenaga, Masaya, et al.
Publicado: (2013)

Effectiveness of plasma treatment on pancreatic cancer cells
por: HATTORI, NORIFUMI, et al.
Publicado: (2015)

Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2016)

Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer
por: Inaoka, Kenichi, et al.
Publicado: (2017)

Tumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus
por: Teramoto, Hitoshi, et al.
Publicado: (2013)

The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma—including the analysis of clinicopathological factors influencing relative dose intensity
por: Yabusaki, Norimitsu, et al.
Publicado: (2016)

Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study
por: Hashimoto, Daisuke, et al.
Publicado: (2022)

Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer
por: Ou, Zheng-Lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ko6von5qfpi9j4f72fk1sapvae